Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Today was the first
View:
Post by Oden6570 on Feb 22, 2021 6:18pm

Today was the first

Time since I first started accumulating TLT shares that I sold some at the high 32 cents. Now I only sold a small portion of my holdings 9k but I was able to buy DM.v 66% price increase at close. The constant shorting and manipulation without intervention is getting to me. White and Hatchey seem quite prepared to legally protect themselves from attack , however they and the company appear toothless fighting for the shareholders. I still have lots of TLT shares maybe , to many. Many venture stocks are performing great and yet here we sit constantly abused and beaten down. Why does this company TLT seem so ignored by investors. I believe selling more of my TLT holdings and buying HPQ an DM may be the way to go. Silence from TLT CEO makes my skin crawl and my wallet light. This guy should be standing on the CN tower shouting out what this tech offers. Not even a God darned Toronto local news article. Is this MGT team so hated now by the investment community, that despite our promising tech nobody f___ing cares !!!!
Comment by charlierock on Feb 22, 2021 7:04pm
Every dog has his day and TLT will be no different. What this company needs is recognition by the masses and this will come with more patient enrolment, positive phase 2 data and approval. Then we will be considered the gold standard. We also have Dr. Coombs COVID research with 1433 and if successful would be icing on the cake. Once these milestones are reached with headlines the general public ...more  
Comment by Oden6570 on Feb 22, 2021 7:18pm
Respectfully excluding covid that is what I have been hearing for the past 7 years.
Comment by Galaxym31 on Feb 22, 2021 8:00pm
yes 7 long years of beatings and massive selling on any positive news 
Comment by Pandora on Feb 22, 2021 8:39pm
Seeing as you are stepping in that direction you may notice LITT as well - up 155%. Also GBLC is behind some of DM's action today I believe. You may also take note of DEFI although it went down with the big dump in crypto today but they recently appointed a guy named Teeka Tiwari to their board - he is one of the top crypto analysts and newsletter writers in N.A. A guy just needs more cash ...more  
Comment by socalbob on Feb 23, 2021 12:47am
Pandora -- you still in CRMD ?  Wild ride the past month, and the rest of this week up to approval could be volatile.  Hopefully TLT can have a similar move later this year with some new patient data.  CRMD one of the few examples of reverse split working and Nasday uplisting seems to have been a boost. But, I'm concerned too many of the WSB types now in CRMD for the quick flip ...more  
Comment by Pandora on Feb 23, 2021 2:39am
No, sad to say I got out of it last summer in the $4.50 range and picked up CYDY in the $2.30 range - CTDY being in the covid therapeutic field. As usual for me the CRMD eventually took off and the CYDY is still struggling through trials. The trial results apparently were just unblinded (finally) and management is having meetings with FDA, HC, and MHRA to discuss results and the path forward. It ...more  
Comment by Bunge on Feb 23, 2021 8:01am
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250